JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

133.74

+0.46%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

133.74

+0.46%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

133.74

+0.46%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

133.74

+0.46%↑

JNJ

227.38

+0.01%↑

ISRG

503.63

-0.84%↓

ABT

109.23

+3.01%↑

MDT

102.96

+1.98%↑

133.74

+0.46%↑

Inicio・Lista de Acciones・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Cerrado

SectorSalud

36.48 -0.92

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

36.12

Máximo

36.76

Métricas clave
By Trading Economics
Ingresos	11M 51M
Ventas	39M 239M
P/B Media del Sector	11.786 90.422
BPA	1.08
Margen de beneficio	21.242
Empleados	268
EBITDA	14M 73M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 meses	+18.76% upside

Dividendos
By Dow Jones
Próximas Ganancias	24 feb 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización de Mercado	464M 2.2B
Apertura anterior	37.4
Cierre anterior	36.48

Noticias sobre sentimiento de mercado

By Acuity

38%

62%

114 / 352 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Weak Bullish Evidence

29.8 / N/A Soporte y Resistencia

Harmony Biosciences Holdings Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

30 ene 2026, 20:14 UTC

Adquisiciones, fusiones, absorciones

Reddy Ice to Buy Arctic Glacier, DOJ Requires Certain Divestitures

30 ene 2026, 23:47 UTC

Adquisiciones, fusiones, absorciones

Negotiations Over $100B OpenAI, Nvidia Deal Stall -- WSJ

30 ene 2026, 23:47 UTC

Adquisiciones, fusiones, absorciones

Nvidia, OpenAI in Talks to Revise Nature of Broader Partnership, Sources Say -- WSJ

30 ene 2026, 23:47 UTC

Adquisiciones, fusiones, absorciones

Nvidia CEO Jensen Huang Has Privately Told Colleagues That Deal Is Non-Binding, Sources Say -- WSJ

30 ene 2026, 23:47 UTC

Adquisiciones, fusiones, absorciones

Nvidia's Huang Has Privately Criticized OpenAI's Business Strategy, Sources Say -- WSJ

30 ene 2026, 23:47 UTC

Adquisiciones, fusiones, absorciones

OpenAI, Nvidia Deal Talks Stalled in Recent Months, Sources Say -- WSJ

30 ene 2026, 23:47 UTC

Adquisiciones, fusiones, absorciones

Nvidia's Huang Expressed Concerns Over Competition OpenAI Faces From Anthropic, Google, Sources Say -- WSJ

30 ene 2026, 23:47 UTC

Adquisiciones, fusiones, absorciones

Nvidia Weighing Equity Investment of Tens of Billions of Dollars Into OpenAI, Sources Say -- WSJ

30 ene 2026, 23:47 UTC

Adquisiciones, fusiones, absorciones

Negotiations Over $100B OpenAI, Nvidia Deal Stall, Sources Say -- WSJ

30 ene 2026, 23:41 UTC

Charlas de Mercado

Deckers Outdoor Seen as Undervalued -- Market Talk

30 ene 2026, 23:12 UTC

Adquisiciones, fusiones, absorciones

Supreme Court of British Columbia Approves Fortescue Purchase of Alta Copper

30 ene 2026, 22:20 UTC

Ganancias

Verizon Posts Strong Subscriber Gains Under New CEO -- WSJ

30 ene 2026, 22:10 UTC

Charlas de Mercado

Disney CEO's Exit Plan Marks Abrupt End to Messy Succession -- Market Talk

30 ene 2026, 21:50 UTC

Charlas de Mercado

Ganancias

Tech, Media & Telecom Roundup: Market Talk

30 ene 2026, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

30 ene 2026, 21:50 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

30 ene 2026, 21:42 UTC

Ganancias

These Stocks Are Today's Movers: Apple, Verizon, SoFi, Sandisk, Western Digital, Unity Software, Exxon, and More -- Barrons.com

30 ene 2026, 21:36 UTC

Ganancias

GE Aerospace and GE Vernova Issue Their Annual Reports. They Contain Messages for Investors. -- Barrons.com

30 ene 2026, 21:33 UTC

Ganancias

Tesla Stock Rebounds From Earnings Dip. SpaceX Is Helping. -- Barrons.com

30 ene 2026, 20:42 UTC

Ganancias

These Stocks Are Today's Movers: Apple, Verizon, SoFi, Sandisk, Western Digital, Unity Software, Exxon, and More -- Barrons.com

30 ene 2026, 20:37 UTC

Adquisiciones, fusiones, absorciones

Why a Ruling Over CK Hutchison's Panama Canal Ports Matters -- and What's Next -- WSJ

30 ene 2026, 20:20 UTC

Charlas de Mercado

Oil Posts Weekly Gains on U.S.-Iran Tensions -- Market Talk

30 ene 2026, 20:13 UTC

Charlas de Mercado

U.S. Natural Gas Futures Rise on Weather-Driven Demand -- Market Talk

30 ene 2026, 19:52 UTC

Ganancias

Visa and Amex Results Point to a Strong Holiday Season for Retailers -- Barrons.com

30 ene 2026, 19:29 UTC

Charlas de Mercado

Ganancias

KLA Guidance Only 'Tepid' as Memory Rally Favors Peers -- Market Talk

30 ene 2026, 19:09 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

30 ene 2026, 19:09 UTC

Charlas de Mercado

Next Canadian Inflation Release Pushed Back a Day to Not Clash With Holiday -- Market Talk

30 ene 2026, 19:07 UTC

Charlas de Mercado

Canada Performing Well Below Economic Potential -- Market Talk

30 ene 2026, 18:46 UTC

Ganancias

'All Boats Are Rising' in Data and Memory, Says Western Digital's CFO. Just Look at the Stocks. -- Barrons.com

30 ene 2026, 18:34 UTC

Ganancias

Exxon, Chevron Post Slimmest Annual Profits Since 2021 -- 2nd Update

Comparación entre iguales

Cambio de precio

Harmony Biosciences Holdings Inc Esperado

Precio Objetivo

By TipRanks

18.76% repunte

Estimación a 12 meses

Media 43.75 USD 18.76%

Máximo 55 USD

Mínimo 32 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Harmony Biosciences Holdings Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

5 ratings

Comprar

Mantener

Vender

De acuerdo con 5 analistas que ofrecen calificaciones bursátiles a para Harmony Biosciences Holdings Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

29.8 / N/ASoporte y Resistencia

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentimiento

By Acuity

114 / 352 Clasificación en Salud

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.